SK287755B6 - Spôsob prípravy derivátov 2-(6-substituovaných-1,3-dioxán-4- yl)octovej kyseliny - Google Patents

Spôsob prípravy derivátov 2-(6-substituovaných-1,3-dioxán-4- yl)octovej kyseliny Download PDF

Info

Publication number
SK287755B6
SK287755B6 SK35-2003A SK352003A SK287755B6 SK 287755 B6 SK287755 B6 SK 287755B6 SK 352003 A SK352003 A SK 352003A SK 287755 B6 SK287755 B6 SK 287755B6
Authority
SK
Slovakia
Prior art keywords
compound
formula
acetic acid
substituted
tert
Prior art date
Application number
SK35-2003A
Other languages
English (en)
Slovak (sk)
Other versions
SK352003A3 (en
Inventor
Jacob Hermanus Mattheus Hero Kooistra
Hubertus Josephus Marie Zeegers
Daniel Mink
Joannes Maria Cornelis Antonius Mulders
Original Assignee
Astrazeneca Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd
Publication of SK352003A3 publication Critical patent/SK352003A3/sk
Publication of SK287755B6 publication Critical patent/SK287755B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
SK35-2003A 2000-07-19 2001-07-12 Spôsob prípravy derivátov 2-(6-substituovaných-1,3-dioxán-4- yl)octovej kyseliny SK287755B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1015744A NL1015744C2 (nl) 2000-07-19 2000-07-19 Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
PCT/NL2001/000535 WO2002006266A1 (en) 2000-07-19 2001-07-12 Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl)acetic acid derivatives

Publications (2)

Publication Number Publication Date
SK352003A3 SK352003A3 (en) 2003-05-02
SK287755B6 true SK287755B6 (sk) 2011-08-04

Family

ID=19771761

Family Applications (2)

Application Number Title Priority Date Filing Date
SK123-2010A SK287756B6 (sk) 2000-07-19 2001-07-12 Deriváty 2-(6-substituovanej-1,3-dioxán-4-yl)octovej kyseliny, soli týchto derivátov a východiskové produkty použité pri spôsobe výroby týchto derivátov
SK35-2003A SK287755B6 (sk) 2000-07-19 2001-07-12 Spôsob prípravy derivátov 2-(6-substituovaných-1,3-dioxán-4- yl)octovej kyseliny

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SK123-2010A SK287756B6 (sk) 2000-07-19 2001-07-12 Deriváty 2-(6-substituovanej-1,3-dioxán-4-yl)octovej kyseliny, soli týchto derivátov a východiskové produkty použité pri spôsobe výroby týchto derivátov

Country Status (30)

Country Link
US (4) US6870059B2 (de)
EP (2) EP1317440B1 (de)
JP (2) JP5006499B2 (de)
KR (3) KR20080078925A (de)
CN (3) CN101081842B (de)
AT (1) ATE340790T1 (de)
AU (2) AU7583001A (de)
BR (1) BR0112535A (de)
CA (1) CA2415963C (de)
CY (1) CY1105881T1 (de)
CZ (1) CZ302718B6 (de)
DE (1) DE60123444T2 (de)
DK (1) DK1317440T3 (de)
EE (1) EE200300024A (de)
ES (2) ES2272506T3 (de)
HK (1) HK1097260A1 (de)
HU (1) HUP0303166A3 (de)
IL (3) IL153980A0 (de)
IS (2) IS2386B (de)
MX (1) MXPA03000498A (de)
NL (1) NL1015744C2 (de)
NO (1) NO328935B1 (de)
NZ (1) NZ523703A (de)
PL (1) PL207115B1 (de)
PT (1) PT1317440E (de)
RU (1) RU2266903C2 (de)
SK (2) SK287756B6 (de)
UA (1) UA77944C2 (de)
WO (1) WO2002006266A1 (de)
ZA (1) ZA200300478B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011120D0 (en) * 2000-05-09 2000-06-28 Avecia Ltd Process
NL1015744C2 (nl) 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
PL366831A1 (en) 2001-07-13 2005-02-07 Astrazeneca Uk Limited Preparation of aminopyrimidine compounds
EP1323717A1 (de) 2001-12-27 2003-07-02 Dsm N.V. Prozess für die Herstellung von 2-(6-Substituierten-1,3-Dioxan-4-yl) Essigsäure Derivaten
EP1375493A1 (de) * 2002-06-17 2004-01-02 Dsm N.V. Verfahren zur Herstellung von Dioxanessigsäureester
GB0218781D0 (en) * 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
JP2006512086A (ja) 2002-09-20 2006-04-13 ダイヴァーサ コーポレイション スタチンおよびスタチン中間体の合成のための酵素化学的方法
US9740817B1 (en) 2002-10-18 2017-08-22 Dennis Sunga Fernandez Apparatus for biological sensing and alerting of pharmaco-genomic mutation
EP1578731B1 (de) * 2002-12-16 2009-11-11 AstraZeneca UK Limited Verfahren zur herstellung von pyrimidinverbindungen
ES2300769T3 (es) 2003-05-02 2008-06-16 Dsm Ip Assets B.V. Proceso para la preparacion de (4-hidroxi-6-oxo-tetrahidropiran-2-il)acetonitrilo y sus derivados.
GB0312896D0 (en) 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
US8346482B2 (en) * 2003-08-22 2013-01-01 Fernandez Dennis S Integrated biosensor and simulation system for diagnosis and therapy
UY28501A1 (es) * 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
GB0321827D0 (en) * 2003-09-18 2003-10-15 Astrazeneca Uk Ltd Chemical compounds
GB0324791D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
DE10352659B4 (de) * 2003-11-11 2007-09-13 Ratiopharm Gmbh Verfahren zur Herstellung von Statinen und Tetrahydropyranonderivate zur Verwendung in dem Verfahren
GB0428328D0 (en) * 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
GB0514078D0 (en) * 2005-07-08 2005-08-17 Astrazeneca Uk Ltd Chemical process
US7264743B2 (en) * 2006-01-23 2007-09-04 Lam Research Corporation Fin structure formation
TW200831469A (en) * 2006-12-01 2008-08-01 Astrazeneca Uk Ltd Chemical process
WO2010118757A1 (en) * 2009-04-15 2010-10-21 Pharmathen S.A. Improved process for the preparation of fluvastatin and salts thereof
GB2482525A (en) * 2010-08-05 2012-02-08 Phoenix Chemicals Ltd A process for the production of acyloxymethyldioxanylacetic derivatives
SI2614057T1 (sl) 2010-09-09 2016-03-31 Dsm Sinochem Pharmaceuticals Netherlands B.V. Soli estrov 7-amino-3,5-dihidroksi heptanojske kisline
SI2616454T1 (sl) 2010-09-16 2015-08-31 Dsm Sinochem Pharmaceuticals Netherlands B.V. Estri heksanojskih kislin, kot vmesne spojine za pripravo atorvastatina
CN103328470A (zh) 2011-01-18 2013-09-25 中化帝斯曼制药有限公司荷兰公司 制备二醇砜的方法
EP2665721B1 (de) 2011-01-18 2015-07-08 DSM Sinochem Pharmaceuticals Netherlands B.V. Methyltetrazolsulfide und -sulfone
US9126975B2 (en) 2011-01-18 2015-09-08 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the preparation of statins in the presence of base
MX359424B (es) 2011-12-09 2018-09-12 Dsm Sinochem Pharm Nl Bv Proceso para la preparación de un precursor de estatina.
CN103987705B (zh) * 2011-12-09 2015-09-30 中化帝斯曼制药有限公司荷兰公司 制备他汀含硫前体的方法
JP6065862B2 (ja) * 2013-04-10 2017-01-25 信越化学工業株式会社 パターン形成方法、レジスト組成物、高分子化合物及び単量体
WO2014203045A1 (en) 2013-06-20 2014-12-24 Lupin Limited A novel, green and cost effective process for synthesis of tert-butyl (3r,5s)-6-oxo-3,5-dihydroxy-3,5-o-isopropylidene-hexanoate
CN105624127B (zh) * 2014-10-28 2019-07-26 上海弈柯莱生物医药科技有限公司 一种葡萄糖脱氢酶及其在合成他汀类药物中间体中的应用

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US544390A (en) * 1895-08-13 Chimney-cowl
GB885516A (en) 1958-01-16 1961-12-28 Arthur Henry Clarkson Higher fatty acid esters of dextran
US3325466A (en) * 1961-01-11 1967-06-13 American Cyanamid Co Tertiary butyl group as a carboxyl protecting group in the synthesis of peptides
US3992432A (en) * 1967-04-05 1976-11-16 Continental Oil Company Phase transfer catalysis of heterogeneous reactions by quaternary salts
DE3929913A1 (de) * 1989-09-08 1991-04-04 Hoechst Ag 4-hydroxytetrahydropyran-2-one sowie die entsprechenden dihydroxycarbonsaeurederivate, salze und ester, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate sowie vorprodukte
GB9005966D0 (en) * 1990-03-16 1990-05-09 May & Baker Ltd New compositions of matter
CA2048716A1 (en) * 1990-08-17 1992-02-18 William B. Mattingly, Iii Absorbent articles with integral release system and methods of making same
US5292891A (en) * 1991-02-21 1994-03-08 Chisso Corporation Optically active 2,2-dimethyl-1,3-dioxin-4-ones and method for preparing same and method for preparing optically active compound for synthesis of physiologically active substance and optically active intermediate compound
JP3097143B2 (ja) 1991-02-21 2000-10-10 チッソ株式会社 生理活性物質合成用光学活性化合物の製造法および光学活性中間体化合物
WO1993006235A1 (en) 1991-09-20 1993-04-01 Zeneca Limited Process for the preparation of enantiomerically pure 4-hydroxytetrahydro-2-pyranone derivatives
WO1993008823A1 (en) * 1991-11-06 1993-05-13 Tanabe Seiyaku Co., Ltd. Guanidinyl and related cell adhesion modulation compounds
US5278313A (en) * 1992-03-27 1994-01-11 E. R. Squibb & Sons, Inc. Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors
US5449793A (en) * 1993-06-04 1995-09-12 Chisso Corporation Process for producing an optically active 1,5-disubstituted-2,4-O-isopropylidene-2,4-dihydroxypentane
US5795749A (en) 1995-04-05 1998-08-18 The Scripps Research Institution Use of 2-deoxyribose-5-phosphate aldolase to prepare 2-deoxyfucose, analogues and derivatives
GB9523924D0 (en) 1995-11-23 1996-01-24 Zeneca Ltd Production of optically active 2-substituted tetrahydropyran-4-ones
FR2741620B1 (fr) * 1995-11-28 1997-12-26 Oreal Procede de preparation de composes a groupement beta-hydroxy -delta-lactone analogues de la (+) compactine et de la (+) mevinoline
US6278001B1 (en) 1995-11-28 2001-08-21 L'oréal Method for preparing (+) compactin and (+) mevinolin analog compounds having a β-hydroxy-δ-lactone grouping
HUP0103659A3 (en) * 1998-04-30 2003-01-28 Kaneka Corp Process for producing 6-cyanomethyl-1,3-dioxane-4-acetic acid derivatives
DE69917204T2 (de) * 1998-08-05 2005-06-23 Kaneka Corp. Verfahren zur herstellung optisch aktiver 2-(6-(hydroxymethyl)-1,3-dioxan-4-yl) -essigsäure-derivate
DE69922348T2 (de) 1998-12-10 2005-12-01 Kaneka Corp. Verfahren zur herstellung eines simvastatin precursors
GB9903472D0 (en) 1999-02-17 1999-04-07 Zeneca Ltd Chemical process
HU227840B1 (en) 1999-05-06 2012-05-02 Egis Gyogyszergyar Nyilvanosan M Kod Ruszvunytarsasag Intermediates of atorvastatin synthesis and process for producing them
ES2219345T3 (es) * 1999-06-04 2004-12-01 Kaneka Corporation Procedimiento para la preparacion de derivados del acido 5-hidroxi-3-oxopentanoico.
WO2001072706A1 (en) * 2000-03-28 2001-10-04 Biocon India Limited Synthesis of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
GB0011120D0 (en) * 2000-05-09 2000-06-28 Avecia Ltd Process
WO2001094337A1 (fr) * 2000-06-05 2001-12-13 Kaneka Corporation Procede de preparation de derives optiquement actifs d'acide 2-[6-(hydroxy-methyl)-1,3-dioxan-4-yl] acetique
NL1015744C2 (nl) * 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
PL366831A1 (en) * 2001-07-13 2005-02-07 Astrazeneca Uk Limited Preparation of aminopyrimidine compounds
EP1323717A1 (de) * 2001-12-27 2003-07-02 Dsm N.V. Prozess für die Herstellung von 2-(6-Substituierten-1,3-Dioxan-4-yl) Essigsäure Derivaten
HUP0500125A3 (en) 2002-02-25 2008-03-28 Biocon Ltd Novel boronate esters and process for their preparation
KR100511533B1 (ko) 2002-04-09 2005-08-31 임광민 키랄 중간체, 그의 제조방법 및 그를 이용한 HMG-CoA환원저해제의 제조방법
EP1375493A1 (de) * 2002-06-17 2004-01-02 Dsm N.V. Verfahren zur Herstellung von Dioxanessigsäureester
GB0218781D0 (en) 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
EP1578731B1 (de) * 2002-12-16 2009-11-11 AstraZeneca UK Limited Verfahren zur herstellung von pyrimidinverbindungen
WO2004103977A2 (en) 2003-05-21 2004-12-02 Ciba Specialty Chemicals Holding Inc. Process for the preparation of pyrimidine derivatives
GB0312896D0 (en) * 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
WO2004113314A1 (en) 2003-06-23 2004-12-29 Biocon Limited Novel boronate esters
UY28501A1 (es) * 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
GB0321827D0 (en) 2003-09-18 2003-10-15 Astrazeneca Uk Ltd Chemical compounds
GB0324791D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
WO2005063728A2 (en) 2003-12-24 2005-07-14 Teva Pharmaceutical Industries Ltd. Process for preparation of statins with high syn to anti ratio
JP4266879B2 (ja) 2004-05-12 2009-05-20 大阪瓦斯株式会社 ガス化炉及び複合リサイクル装置
US7161004B2 (en) 2004-06-21 2007-01-09 Dr. Reddy's Laboratories Limited Processes to produce intermediates for rosuvastatin
GB0428328D0 (en) * 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
GB0514078D0 (en) * 2005-07-08 2005-08-17 Astrazeneca Uk Ltd Chemical process
TW200831469A (en) * 2006-12-01 2008-08-01 Astrazeneca Uk Ltd Chemical process

Also Published As

Publication number Publication date
EP1700854A1 (de) 2006-09-13
NZ523703A (en) 2004-08-27
KR100865016B1 (ko) 2008-10-23
BR0112535A (pt) 2003-07-01
PL359332A1 (en) 2004-08-23
CZ2003163A3 (cs) 2003-05-14
DK1317440T3 (da) 2007-01-08
US20100136339A1 (en) 2010-06-03
ES2387313T3 (es) 2012-09-20
CN1443183A (zh) 2003-09-17
IS8690A (is) 2007-11-15
ATE340790T1 (de) 2006-10-15
IL153980A0 (en) 2003-07-31
KR20070121063A (ko) 2007-12-26
PT1317440E (pt) 2007-01-31
DE60123444D1 (de) 2006-11-09
SK287756B6 (sk) 2011-08-04
EP1317440A1 (de) 2003-06-11
PL207115B1 (pl) 2010-11-30
KR20030040224A (ko) 2003-05-22
JP2012111757A (ja) 2012-06-14
CY1105881T1 (el) 2011-02-02
IS6680A (is) 2003-01-15
CZ302718B6 (cs) 2011-09-21
ZA200300478B (en) 2004-01-26
SK352003A3 (en) 2003-05-02
DE60123444T2 (de) 2007-08-23
JP5006499B2 (ja) 2012-08-22
IS2386B (is) 2008-07-15
HK1097260A1 (en) 2007-06-22
AU2001275830B2 (en) 2006-07-20
CN101081842B (zh) 2012-01-04
US7642363B2 (en) 2010-01-05
EE200300024A (et) 2004-10-15
CA2415963C (en) 2008-02-26
CN1680363A (zh) 2005-10-12
US20050148785A1 (en) 2005-07-07
AU7583001A (en) 2002-01-30
RU2266903C2 (ru) 2005-12-27
HUP0303166A2 (hu) 2003-12-29
US20030158426A1 (en) 2003-08-21
JP2004504315A (ja) 2004-02-12
IL153980A (en) 2006-10-05
IL177824A0 (en) 2006-12-31
UA77944C2 (en) 2007-02-15
HUP0303166A3 (en) 2005-11-28
EP1317440B1 (de) 2006-09-27
NO328935B1 (no) 2010-06-21
NO20030025L (no) 2003-01-03
US7989643B2 (en) 2011-08-02
NL1015744C2 (nl) 2002-01-22
KR20080078925A (ko) 2008-08-28
ES2272506T3 (es) 2007-05-01
CN100378091C (zh) 2008-04-02
US20110251406A1 (en) 2011-10-13
WO2002006266A1 (en) 2002-01-24
US6870059B2 (en) 2005-03-22
MXPA03000498A (es) 2003-06-24
NO20030025D0 (no) 2003-01-03
CA2415963A1 (en) 2002-01-24
CN101081842A (zh) 2007-12-05
EP1700854B1 (de) 2012-05-23

Similar Documents

Publication Publication Date Title
SK287755B6 (sk) Spôsob prípravy derivátov 2-(6-substituovaných-1,3-dioxán-4- yl)octovej kyseliny
AU2001275830A1 (en) Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl)acetic acid derivatives
CN101775000B (zh) 制备(4-羟基-6-氧-四氢吡喃-2-基)乙腈及其衍生物的方法
SK143793A3 (en) The enzymatic process for the stereoselective preparation of a heterobicyclic alcohol enantiomer
AU2006203127B2 (en) Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl) acetic acid derivatives

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20120712